Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Duvelisib by Secura Bio for Splenic Marginal Zone B-Cell Lymphoma: Likelihood of Approval
Duvelisib is under clinical development by Secura Bio and currently in Phase II for Splenic Marginal Zone B-Cell Lymphoma. According...
Duvelisib by Secura Bio for Nodal Marginal Zone B-Cell Lymphoma: Likelihood of Approval
Duvelisib is under clinical development by Secura Bio and currently in Phase II for Nodal Marginal Zone B-Cell Lymphoma. According...
Duvelisib by Secura Bio for Recurrent Head And Neck Squamous Cell Carcinoma: Likelihood of Approval
Duvelisib is under clinical development by Secura Bio and currently in Phase II for Recurrent Head And Neck Squamous Cell...
Duvelisib by Secura Bio for Peripheral T-Cell Lymphomas (PTCL): Likelihood of Approval
Duvelisib is under clinical development by Secura Bio and currently in Phase II for Peripheral T-Cell Lymphomas (PTCL). According to...
Duvelisib by Secura Bio for Anaplastic Large Cell Lymphoma (ALCL): Likelihood of Approval
Duvelisib is under clinical development by Secura Bio and currently in Phase II for Anaplastic Large Cell Lymphoma (ALCL). According...
Duvelisib by Secura Bio for Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy: Likelihood of Approval
Duvelisib is under clinical development by Secura Bio and currently in Phase II for Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy. According...
Duvelisib by Secura Bio for Natural Killer Cell Lymphomas: Likelihood of Approval
Duvelisib is under clinical development by Secura Bio and currently in Phase II for Natural Killer Cell Lymphomas. According to...
Duvelisib by Secura Bio for T-Cell Lymphomas: Likelihood of Approval
Duvelisib is under clinical development by Secura Bio and currently in Phase II for T-Cell Lymphomas. According to GlobalData, Phase...
Duvelisib by Secura Bio for Melanoma: Likelihood of Approval
Duvelisib is under clinical development by Secura Bio and currently in Phase II for Melanoma. According to GlobalData, Phase II...